Business News

AtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008


AtheroGenics, Inc.

2008-07-25 06:15:00

AtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008

ATLANTA, GA–(EMWNews – July 25, 2008) – AtheroGenics, Inc. (NASDAQ: AGIX), a

pharmaceutical company focused on the treatment of chronic inflammatory

diseases, today announced that it will release its second quarter 2008

financial results on Tuesday, August 5, 2008 before the U.S. financial

markets open.

Conference Call and Webcast Information

Company officials will discuss second quarter 2008 financial results via

conference call and webcast on Tuesday, August 5, 2008, at 9:00 a.m. EDT.

Participants may access the live conference call by dialing 877-407-8031

(domestic) or 201-689-8031 (international). To access the webcast, please

visit the AtheroGenics Investor Relations website at

A replay of the conference call will be accessible approximately one hour

after the conclusion of the call by dialing 877-660-6853 (domestic) or

201-612-7415 (international), account number 286, conference ID number

292374. A replay of the webcast will be archived on the Company’s website

until November 6, 2008.

About AtheroGenics

AtheroGenics is focused on the discovery, development and commercialization

of novel drugs for the treatment of chronic inflammatory diseases,

including diabetes and coronary heart disease (atherosclerosis). The

Company’s lead product candidate, AGI-1067, is a novel antioxidant and

anti-inflammatory agent that is currently being evaluated in a Phase III

registration study called ANDES (AGI-1067 as a Novel Anti-Diabetic Agent

Evaluation Study) as an oral treatment for Type 2 diabetes. In addition,

the Company has other clinical and preclinical anti-inflammatory compounds,

including AGI-1096, an oral agent for the prevention of organ transplant

rejection. For more information about AtheroGenics, please visit


AtheroGenics, Inc.
Mark P. Colonnese
Executive Vice President

Media Inquiries
Jayme Maniatis / Dana Conti
Schwartz Communications, Inc.

Investor Inquiries
Lilian Stern
Stern Investor Relations, Inc.

free cash grants, free grant money, free money, cash grants, scholarships, business grants, foundation grants, government grants, debt grants, consolidation, college tuition, financial aid, medical grants, personal grants, medical bills, unsecured loans, no interest loans, financing, loans, capital, non profit organizations

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website now offers Organic Lead Generation & Traffic Solutions

Jordan Taylor

Jordan Taylor is Sr. Editor & writer from San Diego, CA. With over 20 years and 2650+ articles edited rest assured your Press Release will see traction.

Related Articles

Back to top button